USP22 was also identified as an oncogene and associated with many cancers, such as colorectal cancer, breast cancer, oral squamous cell carcinoma, anaplastic thyroid carcinoma, glioma and GC [25, 41, 47–49]. The gene discussed is USP22; the disease is colorectal cancer.